Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C3JV
|
||||
| Former ID |
DNC009977
|
||||
| Drug Name |
1,8-bis-maleimidodiethyleneglycol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530251] | ||
| Formula |
C14H16N2O6
|
||||
| Canonical SMILES |
C1=CC(=O)N(C1=O)CCOCCOCCN2C(=O)C=CC2=O
|
||||
| InChI |
1S/C14H16N2O6/c17-11-1-2-12(18)15(11)5-7-21-9-10-22-8-6-16-13(19)3-4-14(16)20/h1-4H,5-10H2
|
||||
| InChIKey |
FERLGYOHRKHQJP-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530251] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.